このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Kontafarma China Holdings マネジメント
マネジメント 基準チェック /04
現在、CEO に関する十分な情報がありません。
主要情報
Feifei Wang
最高経営責任者
n/a
報酬総額
CEO給与比率 | n/a |
CEO在任期間 | no data |
CEOの所有権 | n/a |
経 営陣の平均在職期間 | データなし |
取締役会の平均在任期間 | データなし |
経営陣の近況
Recent updates
Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns
May 31There's No Escaping Kontafarma China Holdings Limited's (HKG:1312) Muted Revenues Despite A 61% Share Price Rise
May 24Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?
Dec 28Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?
Sep 01Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?
Dec 29Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?
Sep 15Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?
Apr 20Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?
Nov 04Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares
Feb 18These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively
Dec 07CEO(最高経営責任者
Feifei Wang
no data
在職期間
Mr. Feifei Wang is Executive Chairman & President of Kontafarma China Holdings Limited from June 7, 2024.